Work

Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis

Year: 2024

Type: article

Source: DOAJ (DOAJ: Directory of Open Access Journals)

DOI: 10.30476/mejc.2024.100077.1969

Authors: Meysam Seyedifar, Behzad Fatemi, Fatemeh Soleymani, Menhajuddin Sabouri

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W6908811410

FWCI:

Cites:

Cited by:

Related to: